NDC 23243-4740 - GEN-GARD Soluble Powder
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 23243-4740
- Package NDCs from labels
- 23243-4740-3
- Manufacturer
- Huvepharma, Inc | Huvepharma EOOD
- Effective date
- 2024-06-04
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| GEN-GARD Soluble Powder - Huvepharma, Inc | Huvepharma EOOD | Huvepharma, Inc | Huvepharma EOOD | 2024-06-04 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 23243-4740-3 | GEN-GARDSoluble Powder | 360 g in 1 JAR | POWDER, FOR SOLUTION | 360 | 4 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 23243-4740 | GEN-GARD SOLUBLE POWDER (GENTAMICIN SULFATE) POWDER, FOR SOLUTION [HUVEPHARMA, INC] | 4 | 1 package rows | 20240730_bd4fe190-eec0-4e6e-a267-babf1934f845.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Gentamicin Sulfate | GENTAMICIN SULFATE | Hospira, Inc. | 977180b3-a222-4282-d485-4a3217674305 | 2026-05-20 | Boxed warning, Warnings, Adverse reactions | 8X7386QRLV |
| Gentamicin Sulfate | GENTAMICIN SULFATE | Cardinal Health 107, LLC | 5113bfad-42ca-4bb8-9343-0b08c6cd03f0 | 2026-05-08 | Boxed warning, Warnings, Adverse reactions | 8X7386QRLV |
| Gentamicin Sulfate | GENTAMICIN SULFATE | Preferred Pharmaceuticals Inc. | 5ac8ea7a-ee89-49f5-8d30-6dbb56503d94 | 2026-05-05 | Warnings, Adverse reactions | 8X7386QRLV |
| Gentamicin Sulfate Opth Solution | GENTAMICIN SULFATE OPTH SOLUTION | Direct_Rx | e1a5bc32-f9a0-6b33-e053-2995a90ab9ac | 2026-03-17 | Warnings, Adverse reactions | 8X7386QRLV |
| Gentamicin | GENTAMICIN | Eugia US LLC | 60ca1487-392d-4721-aa45-3de38722896c | 2026-01-29 | Boxed warning, Warnings, Adverse reactions | 8X7386QRLV |
| Gentamicin | GENTAMICIN | Eugia US LLC | f8c608b3-50b8-4d5d-9e8a-e92c0d2e3cdc | 2026-01-27 | Boxed warning, Warnings, Adverse reactions | 8X7386QRLV |
| Gentamicin | GENTAMICIN SULFATE | Henry Schein, Inc | 84f6eb1c-a287-489a-8c3e-aa5954cf1992 | 2025-10-31 | Boxed warning, Warnings, Adverse reactions | 8X7386QRLV |
| Gentamicin Sulfate | GENTAMICIN SULFATE | Henry Schein, Inc. | 913a36c3-50d6-429a-a8dd-a03126d2ca08 | 2025-10-31 | Boxed warning, Warnings, Adverse reactions | 8X7386QRLV |
| Gentamicin Sulfate | GENTAMICIN SULFATE | Medical Purchasing Solutions, LLC | 3532bb39-a1a6-9d67-e063-6294a90abc0c | 2025-05-15 | Boxed warning, Warnings, Adverse reactions | 8X7386QRLV |
| Gentamicin Sulfate | GENTAMICIN SULFATE | Proficient Rx LP | 5193ed8d-44c9-46fe-924d-93aaea922cfd | 2025-05-01 | Warnings, Adverse reactions | 8X7386QRLV |
| Gentamicin Sulfate | GENTAMICIN SULFATE | NuCare Pharmaceuticals,Inc. | 0bef2a01-69d0-cf50-e063-6294a90a4c52 | 2025-02-03 | Warnings, Adverse reactions | 8X7386QRLV |
| Gentamicin | GENTAMICIN | Fresenius Kabi USA, LLC | 63413469-c676-48a3-a945-7d2489b535ef | 2024-10-14 | Boxed warning, Warnings, Adverse reactions | 8X7386QRLV |
| Gentamicin | GENTAMICIN SULFATE | Fresenius Kabi USA, LLC | 84f5c763-1cd3-4d85-9afb-934db8666fbf | 2024-10-11 | Boxed warning, Warnings, Adverse reactions | 8X7386QRLV |
| Gentamicin Sulfate | GENTAMICIN SULFATE | NuCare Pharmaceuticals, Inc. | 4add8f7b-48f0-6b6a-e054-00144ff88e88 | 2024-08-14 | Warnings, Adverse reactions | 8X7386QRLV |
| Gentamicin Sulfate | GENTAMICIN SULFATE | Bausch & Lomb Incorporated | 41d01350-5c4b-42fc-be5f-986ceec02bd3 | 2024-07-22 | Warnings, Adverse reactions | 8X7386QRLV |
| Gentamicin Sulfate | GENTAMICIN SULFATE | NuCare Pharmaceuticals,Inc. | 82595309-304e-a221-e053-2991aa0ac0a9 | 2024-06-14 | Warnings, Adverse reactions | 8X7386QRLV |
| GENTAMICIN SULFATE | GENTAMICIN SULFATE | NuCare Pharmaceuticals,Inc. | 85424b40-5c2d-421d-e053-2991aa0a7771 | 2024-06-14 | Warnings, Adverse reactions | 8X7386QRLV |
| GENTAMICIN | GENTAMICIN | HF Acquisition Co LLC, DBA HealthFirst | c1ff0cdc-ac5d-30ca-e053-2a95a90a5066 | 2024-01-30 | Boxed warning, Warnings, Adverse reactions | 8X7386QRLV |
| GENTAMICIN SULFATE | GENTAMICIN SULFATE | HF Acquisition Co LLC, DBA HealthFirst | e9fbe619-2afe-f1d7-e053-2a95a90aab29 | 2024-01-27 | Boxed warning, Warnings, Adverse reactions | 8X7386QRLV |
| Gentamicin Sulfate | GENTAMICIN SULFATE | Padagis Israel Pharmaceuticals Ltd | a9486ae1-350b-41c5-ae0c-a4d692bb2dfd | 2024-01-15 | Adverse reactions | 8X7386QRLV |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.